|
C15ORF44 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.33460000051322E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11159999982569E-07 |
| Normal-vs-Stage2 |
4.018000E-03 |
| Normal-vs-Stage3 |
8.156500E-04 |
| Normal-vs-Stage4 |
2.540400E-02 |
| Stage1-vs-Stage2 |
8.648800E-01 |
| Stage1-vs-Stage3 |
9.658800E-01 |
| Stage1-vs-Stage4 |
4.261200E-01 |
| Stage2-vs-Stage3 |
9.149000E-01 |
| Stage2-vs-Stage4 |
5.582400E-01 |
| Stage3-vs-Stage4 |
4.940400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.08920000019275E-07 |
| Normal-vs-AfricanAmerican |
1.187650E-04 |
| Normal-vs-Asian |
1.129950E-02 |
| Caucasian-vs-AfricanAmerican |
3.934800E-01 |
| Caucasian-vs-Asian |
9.278400E-01 |
| AfricanAmerican-vs-Asian |
6.749400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.80039999575499E-08 |
| Normal-vs-Female |
2.243500E-03 |
| Male-vs-Female |
2.577800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.624200E-04 |
| Normal-vs-Extreme_Weight |
1.98520000438407E-08 |
| Normal-vs-Obese |
6.07670000000171E-05 |
| Normal-vs-Extreme_Obese |
1.880270E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.747000E-01 |
| Normal_Weight-vs-Obese |
9.263400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.280800E-01 |
| Extreme_Weight-vs-Obese |
1.827620E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.249000E-01 |
| Obese-vs-Extreme_Obese |
5.720800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.818700E-03 |
| Normal-vs-Age(41-60Yrs) |
3.96230000000442E-05 |
| Normal-vs-Age(61-80Yrs) |
6.98980000546356E-08 |
| Normal-vs-Age(81-100Yrs) |
3.8737999996652E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.633200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.690800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.847730E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.296440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.082300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.012440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.43900000004749E-06 |
| Normal-VS-Type2 PRCC |
3.23700000137706E-08 |
| Normal-VS-KIRP CIMP |
7.024100E-02 |
| Normal-VS-Unclassified PRCC |
2.006000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.065700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.515400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.067400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.303570E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.295400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.961000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.33630001192864E-09 |
| Normal-vs-N1 |
5.562100E-02 |
| Normal-vs-N2 |
4.178000E-04 |
| N0-vs-N1 |
9.084500E-03 |
| N0-vs-N2 |
5.025200E-01 |
| N1-vs-N2 |
1.230640E-01 |
|
|
